What Happened?
, -based Garuda Therapeutics Appointed Roger Sawhney as Chief Financial Officer
About the Company
Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 70 diseases.
About the Person
Roger Sawhney is Chief Financial Officer at Garuda Therapeutics. Previously, Roger held various senior HR leadership roles in the industry.
Info Source
News
Short Profile